Skip to main content
Advertisement
  • Other Publications
    • EMBO Press
    • EMBO Molecular Medicine (Home)
    • The EMBO Journal
    • EMBO reports
    • Molecular Systems Biology
    • Life Science Alliance
Login

   

Search

Advanced Search

Journal

  • Home
  • Latest Online
  • Current Issue
  • Archive
  • Article Collections
  • Subject Collections

Authors & Referees

  • Submit
  • Author Guidelines
  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Referee Guidelines
  • Bibliometrics
  • Open Access

Info

  • E-Mail Editorial Office
  • Alerts
  • RSS Feeds
  • Reprints & Permissions
  • Advertise & Sponsor
  • Media Partners
  • News & Press
  • Customer Service
  • Home
  • Latest Online

Open Access

Report

Defining the optimal animal model for translational research using gene set enrichment analysis

Christopher Weidner, Matthias Steinfath, Elisa Opitz, Michael Oelgeschläger, View ORCID ProfileGilbert Schönfelder
DOI 10.15252/emmm.201506025 | Published online 15.06.2016
EMBO Molecular Medicine (2016) e201506025
Christopher Weidner
Department of Experimental Toxicology and ZEBET, German Federal Institute for Risk Assessment (BfR), Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Steinfath
Department of Experimental Toxicology and ZEBET, German Federal Institute for Risk Assessment (BfR), Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisa Opitz
Department of Experimental Toxicology and ZEBET, German Federal Institute for Risk Assessment (BfR), Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Oelgeschläger
Department of Experimental Toxicology and ZEBET, German Federal Institute for Risk Assessment (BfR), Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilbert Schönfelder
Department of Experimental Toxicology and ZEBET, German Federal Institute for Risk Assessment (BfR), Berlin, GermanyDepartment of Clinical Pharmacology and Toxicology, Charité‐Universitätsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Author Affiliations

  1. Christopher Weidner1,
  2. Matthias Steinfath1,
  3. Elisa Opitz1,
  4. Michael Oelgeschläger1 and
  5. Gilbert Schönfelder*,1,2
  1. 1Department of Experimental Toxicology and ZEBET, German Federal Institute for Risk Assessment (BfR), Berlin, Germany
  2. 2Department of Clinical Pharmacology and Toxicology, Charité‐Universitätsmedizin Berlin, Berlin, Germany
  1. ↵*Corresponding author. Tel: +49 30 18412 2286; E‐mail: gilbert.schoenfelder{at}bfr.bund.de
View Abstract
  • Article
  • Figures & Data
  • Transparent Process
Loading

Article Information

DOI 
https://doi.org/10.15252/emmm.201506025
PubMed 
27311961
Print ISSN 
1757-4676
Online ISSN 
1757-4684
History 
  • Published online June 15, 2016.

Author Information

  1. Christopher Weidner1,
  2. Matthias Steinfath1,
  3. Elisa Opitz1,
  4. Michael Oelgeschläger1 and
  5. Gilbert Schönfelder*,1,2
  1. 1Department of Experimental Toxicology and ZEBET, German Federal Institute for Risk Assessment (BfR), Berlin, Germany
  2. 2Department of Clinical Pharmacology and Toxicology, Charité‐Universitätsmedizin Berlin, Berlin, Germany
  1. ↵*Corresponding author. Tel: +49 30 18412 2286; E‐mail: gilbert.schoenfelder{at}bfr.bund.de
View Full Text
Next Article in this Issue
Back to top

  • PDF
  • Share
  • Export
  • Print
Loading

PDF

In this Issue
Volume 11, Issue 2
01 February 2019
EMBO Molecular Medicine: 11 (2)
About the cover
Alert me when this article is cited
Alert me if a correction is posted

Article

  • Article
    • Abstract
    • Synopsis
    • Introduction
    • Results
    • Discussion
    • Materials and Methods
    • Author contributions
    • Conflict of interest
    • Expanded View
    • Acknowledgments
    • References
  • Figures & Data
  • Transparent Process

Related Content

More Reports

  • A dual‐AAV approach restores fast exocytosis and partially rescues auditory function in deaf otoferlin knock‐out mice
    Hanan Al‐Moyed, Andreia P Cepeda, SangYong Jung, Tobias Moser, Sebastian Kügler, Ellen Reisinger
    EMBO Molecular Medicine 11: e9396
  • Comprehensive evaluation of coding region point mutations in microsatellite‐unstable colorectal cancer
    Johanna Kondelin, Kari Salokas, Lilli Saarinen, Kristian Ovaska, Heli Rauanheimo, Roosa‐Maria Plaketti, Jiri Hamberg, Xiaonan Liu, Leena Yadav, Alexandra E Gylfe, Tatiana Cajuso, Ulrika A Hänninen, Kimmo Palin, Heikki Ristolainen, Riku Katainen, Eevi Kaasinen, Tomas Tanskanen, Mervi Aavikko, Minna Taipale, Jussi Taipale, Laura Renkonen‐Sinisalo, Anna Lepistö, Selja Koskensalo, Jan Böhm, Jukka‐Pekka Mecklin, Halit Ongen, Emmanouil T Dermitzakis, Outi Kilpivaara, Pia Vahteristo, Mikko Turunen, Sampsa Hautaniemi, Sari Tuupanen, Auli Karhu, Niko Välimäki, Markku Varjosalo, Esa Pitkänen, Lauri A Aaltonen
    EMBO Molecular Medicine 10: e8552
  • mitoTev‐TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels
    Claudia V Pereira, Sandra R Bacman, Tania Arguello, Ugne Zekonyte, Sion L Williams, David R Edgell, Carlos T Moraes
    EMBO Molecular Medicine 10: e8084
More Report

Related Articles

Cited By...

Request Permissions

Subject Areas

  • Immunology
  • Systems Medicine

Journal

  • Latest Online
  • Current Issue
  • Archive
  • Focus Pages
  • Bibliometrics
  • E-Mail Editorial Office
  • Privacy Policy

Authors & References

  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Author Guidelines
  • Referee Guidelines
  • Open Access
  • Submit

Info

  • Alerts
  • RSS Feeds
  • Reprints & Permissions
  • Advertise & Sponsor
  • News & Press
  • Customer Service

EMBO

  • Funding & Awards
  • Events
  • Science Policy
  • Members
  • About EMBO

Online ISSN  1757-4684

Copyright© 2019 EMBO

This website is best viewed using the latest versions of all modern web browsers. Older browsers may not display correctly.